Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-39008639

ABSTRACT

The authors describe a kidney transplant procedure using a living donor with a large cyst and double arteries. Due to the lack of regular transplant activity from a deceased donors, we decided to use the, so called, expanded criteria living donors, which means older age (more than 65 years), hypertension, some structural anomalies of the kidneys (cysts, multiple renal arteries), ABO incompatible kidney transplant, etc. The surgical procedure was the unroofing of a large cyst and wadding with perirenal fat. The 10 years survival rate is quite successful and we can recommend it.


Subject(s)
Kidney Transplantation , Living Donors , Renal Artery , Humans , Kidney Transplantation/methods , Renal Artery/surgery , Renal Artery/abnormalities , Aged , Treatment Outcome , Male , Female , Kidney Diseases, Cystic/surgery , Age Factors
2.
Exp Clin Transplant ; 21(5): 471-476, 2023 05.
Article in English | MEDLINE | ID: mdl-37334693

ABSTRACT

Celiac-like disease and celiac sprue associated with widespread use of mycophenolic acid are among the most frequent complications of renal transplant. Most cases have been observed in patients receiving mycophenolate mofetil; however, there have been rare instance after administration of enteric-coated mycophenolate sodium. Here, we describe 4 renal transplant recipients with celiac-like duodenopathy that occurred in association with enteric-coated mycophenolate sodium treatment in a time period of 14 to 19 years after living donor kidney transplant. Three of 4 patients had diarrhea, and all 4 patients had marked loss of body weight. Esophago-gastroduodenoscopy was not diagnostically helpful; however, randomly performed duodenal biopsies showed mild villous atrophy and intraepithelial lymphocytosis. Replacement of enteric-coated mycophenolate sodium with azathioprine was successful with stopping diarrhea, allowing regained body weight, and stabilization of renal function. This potential complication in kidney transplant recipients can occur more than a decade after transplant. Diagnosis and treatment initiation are urgent to cure this disease.


Subject(s)
Duodenal Diseases , Kidney Transplantation , Humans , Mycophenolic Acid/adverse effects , Immunosuppressive Agents/adverse effects , Kidney Transplantation/adverse effects , Immunosuppression Therapy , Diarrhea/chemically induced , Diarrhea/diagnosis , Transplant Recipients , Kidney/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...